Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 613737, 8 pages
http://dx.doi.org/10.1155/2011/613737
Research Article

Attenuation of Diabetic Nephropathy in Otsuka Long-Evans Tokushima Fatty (OLETF) Rats with a Combination of Chinese Herbs (Tangshen Formula)

1Department of Pharmacology, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, No. 2 Yinghua Dongjie, Hepingli, Beijing 100029, China
2Faculty of Pharmacy, University of Manitoba, 750 McDermot Avenue, Winnipeg, MB, Canada R3E 0T5
3Faculty of Medicine, University of Manitoba, 750 McDermot Avenue, Winnipeg, MB, Canada R3E 0T5
4Dongzhimen Hospital, Beijing University of Chinese Medicine, No. 5 Hai Yun Cang, Dongcheng District, Beijing 100700, China

Received 21 July 2010; Revised 22 November 2010; Accepted 13 December 2010

Copyright © 2011 Haojun Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Forbes, K. Fukami, and M. E. Cooper, “Diabetic nephropathy: where hemodynamics meets metabolism,” Experimental and Clinical Endocrinology and Diabetes, vol. 115, no. 2, pp. 69–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. L. Gross, M. J. de Azevedo, S. P. Silveiro, L. H. Canani, M. L. Caramori, and T. Zelmanovitz, “Diabetic nephropathy: diagnosis, prevention, and treatment,” Diabetes Care, vol. 28, no. 1, pp. 164–176, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Sego, “Pathophysiology of diabetic nephropathy,” Nephrology Nursing Journal, vol. 34, no. 6, pp. 631–633, 2007. View at Google Scholar · View at Scopus
  4. K. Kawano, T. Hirashima, S. Mori, Y. Saitoh, M. Kurosumi, and T. Natori, “Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long-Evans Tokushima Fatty (OLETF) strain,” Diabetes, vol. 41, no. 11, pp. 1422–1428, 1992. View at Google Scholar · View at Scopus
  5. K. I. Sugimoto, S. Tsuruoka, and A. Fujimura, “Hyperlipidaemia and the progression of nephropathy in OLETF rats: effect of angiotensin-converting enzyme inhibitor, enalapril,” Clinical and Experimental Pharmacology and Physiology, vol. 26, no. 8, pp. 601–607, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Okumura, M. Imanishi, T. Yamashita et al., “Renal production of thromboxane and prostaglandins in a rat model of type 2 diabetes,” Life Sciences, vol. 66, no. 5, pp. 371–377, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. A. J. H. Julian Critchley, H. L. Zhao, B. Tomlinson et al., “Management of nephropathy in patients with type 2 diabetes,” Chinese Medical Journal, vol. 115, no. 1, pp. 129–135, 2002. View at Google Scholar · View at Scopus
  8. L. Yang, P. Li, Y. Chen et al., “The effect of Tangshen Formula on patients with type 2 diabetic kidney disease: a multicenter randomized placebo-controlled trial,” in Proceedings of the 53rd Annual Meeting of the Japanese Society of Nephrology, Kobe, Japan, June 2010.
  9. A. P. Brown, N. Dinger, and B. S. Levine, “Stress produced by Gavage administration in the rat,” Contemporary Topics in Laboratory Animal Science, vol. 39, no. 1, pp. 17–21, 2000. View at Google Scholar · View at Scopus
  10. J. M. Forbes, V. Thallas, M. C. Thomas et al., “The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes,” FASEB Journal, vol. 17, no. 12, pp. 1762–1764, 2003. View at Google Scholar · View at Scopus
  11. M. Veniant, D. Heudes, J. P. Clozel, P. Bruneval, and J. Menard, “Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats,” Kidney International, vol. 46, no. 2, pp. 421–429, 1994. View at Google Scholar · View at Scopus
  12. P. Rossing, “Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history,” Current Diabetes Reports, vol. 6, no. 6, pp. 479–483, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. E. M. Vivian and G. B. Rubinstein, “Pharmacologic management of diabetic nephropathy,” Clinical Therapeutics, vol. 24, no. 11, pp. 1741–1756, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. S. B. Gurley and T. M. Coffman, “The renin-angiotensin system and diabetic nephropathy,” Seminars in Nephrology, vol. 27, no. 2, pp. 144–152, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Chen, Y. Wan, R. Bian et al., “Mechanism of Chinese herbal medicine delaying glomerulosclerosis in diabetic nephropathy,” Zhongguo Zhongyao Zazhi, vol. 35, no. 4, pp. 525–530, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Zhao, “A survey of treatment of diabetic complications with Chinese drugs,” Journal of Traditional Chinese Medicine, vol. 25, no. 2, pp. 153–159, 2005. View at Google Scholar · View at Scopus
  17. K. Kawano, S. Mori, T. Hirashima, Z. W. Man, and T. Natori, “Examination of the pathogenesis of diabetic nephropathy in OLETF rats,” Journal of Veterinary Medical Science, vol. 61, no. 11, pp. 1219–1228, 1999. View at Google Scholar · View at Scopus
  18. G. Wolf, S. Chen, and F. N. Ziyadeh, “From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy,” Diabetes, vol. 54, no. 6, pp. 1626–1634, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Wolf and F. N. Ziyadeh, “Cellular and molecular mechanisms of proteinuria in diabetic nephropathy,” Nephron—Physiology, vol. 106, no. 2, pp. p26–p31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. J. Chen, Y. B. Yang, and S. M. Huang, “Expression of VEGF in kidney of diabetic rats,” Journal of Sichuan University, vol. 38, no. 4, pp. 633–636, 2007. View at Google Scholar · View at Scopus
  21. R. D. Harris, M. W. Steffes, R. W. Bilous, D. E. R. Sutherland, and S. M. Mauer, “Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes,” Kidney International, vol. 40, no. 1, pp. 107–114, 1991. View at Google Scholar · View at Scopus
  22. C. W. Heilig, L. A. Concepcion, B. L. Riser et al., “Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype,” Journal of Clinical Investigation, vol. 96, no. 4, pp. 1802–1814, 1995. View at Google Scholar · View at Scopus
  23. C. P. Kovesdy, K. Sharma, and K. Kalantar-Zadeh, “Glycemic control in diabetic CKD patients: where do we stand?” American Journal of Kidney Diseases, vol. 52, no. 4, pp. 766–777, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. I. M. Stratton, A. I. Adler, H. A. W. Neil et al., “Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study,” British Medical Journal, vol. 321, no. 7258, pp. 405–412, 2000. View at Google Scholar · View at Scopus
  25. A. Al-Shurbaji, E. Humble, M. Rudling, B. Lindenthal, and L. Berglund, “Hepatic cholesterol metabolism in experimental nephrotic syndrome,” Lipids, vol. 33, no. 2, pp. 165–169, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Trevisan, A. R. Dodesini, and G. Lepore, “Lipids and renal disease,” Journal of the American Society of Nephrology, vol. 17, no. 2, pp. S145–S147, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. J. L. Mehta, N. Rasouli, A. K. Sinha, and B. Molavi, “Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction,” International Journal of Biochemistry and Cell Biology, vol. 38, no. 5-6, pp. 794–803, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. H. C. Chen, J. Y. Guh, S. J. Shin, J. H. Tsai, and Y. H. Lai, “Reactive oxygen species enhances endothelin-1 production of diabetic rat glomeruli in vitro and in vivo,” Journal of Laboratory and Clinical Medicine, vol. 135, no. 4, pp. 309–315, 2000. View at Google Scholar · View at Scopus
  29. F. Bonnet and M. E. Cooper, “Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies,” Diabetes and Metabolism, vol. 26, no. 4, pp. 254–264, 2000. View at Google Scholar · View at Scopus
  30. A. Krämer-Guth, T. Quaschning, S. Gheiber, and C. Wanner, “Potential role of lipids in the progression of diabetic nephropathy,” Clinical Nephrology, vol. 46, no. 4, pp. 262–265, 1996. View at Google Scholar · View at Scopus
  31. M. Ravid, L. Neumann, and M. Lishner, “Plasma lipids and the progression of nephropathy in diabetes mellitus type II: effect of ACE inhibitors,” Kidney International, vol. 47, no. 3, pp. 907–910, 1995. View at Google Scholar · View at Scopus
  32. S. B. Choi, B. S. Ko, S. K. Park, J. S. Jang, and S. Park, “Insulin sensitizing and α-glucoamylase inhibitory action of sennosides, rheins and rhaponticin in Rhei Rhizoma,” Life Sciences, vol. 78, no. 9, pp. 934–942, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. G. Zhang, H. G. Zhang, G. Y. Zhang et al., “Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action,” Clinical and Experimental Pharmacology and Physiology, vol. 35, no. 10, pp. 1238–1244, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Kumar, M. M. Khan, A. K. Khanna et al., “Lipid lowering activity of anthocephalus indicus root in hyperlipidemic rats,” Evidence-Based Complementary and Alternative Medicine, vol. 7, no. 3, pp. 317–322, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. K. S. Brimble, A. McFarlane, N. Winegard, M. Crowther, and D. N. Churchill, “Effect of chronic kidney disease on red blood cell rheology,” Clinical Hemorheology and Microcirculation, vol. 34, no. 3, pp. 411–420, 2006. View at Google Scholar · View at Scopus
  36. M. P. Gordge, R. W. Faint, P. B. Rylance, and G. H. Neild, “Abnormal blood rheology in progressive renal failure: a factor in non-immune glomerular injury?” Nephrology Dialysis Transplantation, vol. 3, no. 3, pp. 257–262, 1988. View at Google Scholar · View at Scopus
  37. M. P. Gordge, A. Patel, R. W. Faint, P. B. Rylance, and G. H. Neild, “Blood hyperviscosity and its relationship to progressive renal failure in patients with diabetic nephropathy,” Diabetic Medicine, vol. 7, no. 10, pp. 880–886, 1990. View at Google Scholar · View at Scopus
  38. N. H. Schut, E. C. van Arkel, M. R. Hardeman, H. J. Bilo, R. P. Michels, and J. Vreeken, “Blood and plasma viscosity in diabetes: possible contribution to late organ complications?” Diabetes Research, vol. 19, no. 1, pp. 31–35, 1992. View at Google Scholar · View at Scopus